TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes

mehr
Titel TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Medien Breast Care
Band 13
Verfasser Franziska Würfel, Ramona Erber, Hanna Huebner, Alexander Hein, Michael P. Lux, Sebastian Jud, .. et al., Prof. Dr. Bernhard Volz, .. et al., Matthias Rübner
Seiten 8-14
Veröffentlichungsdatum 28.02.2018
Zitation Würfel, Franziska; Erber, Ramona; Huebner, Hanna; Hein, Alexander; Lux, Michael P.; Jud, Sebastian; et al., ..; Volz, Bernhard; et al., ..; Rübner, Matthias (2018): TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes. Breast Care 13, 8-14. DOI: 10.1159/000486949